A phase 2 efficacy study of CIM101 in the patients with Non-small-cell-lung-cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update:
05 May 2021
Price :
$35
*
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.